#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Obesity Familial hypertriglyceridaemia Cutaneous T-cell lymphoma refractory Glioma Follicular lymphoma stage II Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Duchenne muscular dystrophy Leber's congenital amaurosis Head and neck cancer Retinitis pigmentosa Nephroblastoma Dilated cardiomyopathy Hepatic angiosarcoma Angiosarcoma non-metastatic Acute on chronic liver failure More trials…

    Learn about Rare Diseases

    Gastrointestinal stromal tumour – Diagnostics Primary biliary cholangitis – Basic Information Pulmonary sarcoidosis – Diagnostics Leiomyosarcoma recurrent – Diagnostics Ewing’s sarcoma – Treatment Nephrotic syndrome Myelodysplastic syndrome with excess blasts – Diagnostics Bronchopulmonary dysplasia Turner’s syndrome – Treatment Nephroblastoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Hypromellose Deucravacitinib Sodium Thiosulfate Acasunlimab Remdesivir Zamtocabtagene Autoleucel Famotidine Sotagliflozin Fluvastatin Pamiparib Cipepofol Dulaglutide Botulinum Toxin Type A Proguanil Hydrochloride Elenestinib Phosphate SONLICROMANOL HYDROCHLORIDE Prednisolone Sodium Phosphate Osilodrostat Solifenacin Succinate Candesartan More therapies…

    Learn about Your Condition

    Arthralgia Ocular lymphoma Syphilis Obstructive pancreatitis Non-Hodgkin's lymphoma Acoustic neuroma Merycism Pulmonary vascular disorder Double hit lymphoma Still's disease Cardiac failure chronic Synovial sarcoma recurrent Thrombolysis Conjunctivitis allergic Compulsive sexual behaviour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Lu AG13909 in Adults with Cushing’s Disease to Evaluate Safety and Effectiveness

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pituitary-dependent Cushing’s syndrome
    Investigated Drugs:
    • Ag13909
    France Hungary Italy Poland Romania Spain

  • Study on the Effectiveness and Safety of Prednisone for Patients with Drug-Induced Liver Injury (DILI)

    Recruiting

    2 1 1
    Investigated Drugs:
    • Microcrystalline Cellulose
    • Prednisone
    Spain

  • Study on Reducing HPV Infectivity in HPV-Positive Women Using 9vHPV Vaccine

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Papilloma viral infection
    Investigated Drugs:
    • Human Papillomavirus Type 11 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 16 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 18 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    Spain

  • Study on the Effectiveness and Safety of Iptacopan with Drug Combination for Adults with Active Lupus Nephritis Class III-IV, +/- V

    Recruiting

    2 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Iptacopan Hydrochloride
    • Mycophenolate Sodium
    • Iptacopan
    France Germany Hungary Portugal Spain

  • Study on Exercise, Mediterranean Diet, and Aspirin for Women with Infertility Undergoing In Vitro Fertilization

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility female
    Investigated Drugs:
    • Acetylsalicylic Acid
    Spain

  • Study on Patritumab Deruxtecan and Zirconium (89Zr) Patritumab Deruxtecan for Patients with Advanced EGFR Mutation Positive Lung Cancer

    Recruiting

    2 1 1
    Investigated Drugs:
    • Zirconium (89Zr) Patritumab Deruxtecan
    • Patritumab Deruxtecan
    The Netherlands
Previous Page
1 … 527 528 529 530 531 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!